M. Terminiello

Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With <i>RAS</i> Wild-type Metastatic Colorectal Cancer

Erika Martinelli, Giulia Martini, Vincenzo Famiglietti et al. · JAMA Oncology · 2021 · 185 citations · Full text

Medicine, Oncology, Pharmacology +17

Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience

Pietro Paolo Vitiello, Vincenzo De Falco, Emilio Francesco Giunta et al. · Cancers · 2019 · 65 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients

Emilio Francesco Giunta, Giusi Barra, Vincenzo De Falco et al. · Scientific Reports · 2020 · 39 citations · Full text

Medicine, Immunology, Oncology +17

397O Avelumab plus cetuximab in pre-treated RAS wild type metastatic colorectal cancer patients as a rechallenge strategy: The phase II CAVE (cetuximab-avelumab) mCRC study

Erika Martinelli, Giulia Martini, Teresa Troiani et al. · Annals of Oncology · 2020 · 23 citations

Medicine, Oncology, Pharmacology +12

Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania ‘Luigi Vanvitelli’

L. Poliero, Pietro Paolo Vitiello, Davide Ciardiello et al. · ESMO Open · 2020 · 22 citations · Full text

Medicine, Oncology, Pathology +17